174 related articles for article (PubMed ID: 26662389)
1. Significant association between the MTHFR A1298C polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Chang W; Meng Q; Liu JH; Wu LX; Chen Y; Chen SD
Genet Mol Res; 2015 Dec; 14(4):15972-80. PubMed ID: 26662389
[TBL] [Abstract][Full Text] [Related]
2. The association between MTHFR gene polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
Qin X; Peng Q; Chen Z; Deng Y; Huang S; Xu J; Li H; Li S; Zhao J
PLoS One; 2013; 8(2):e56070. PubMed ID: 23457501
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of MTHFR C677T and A1298C gene polymorphisms: association with the risk of hepatocellular carcinoma.
Qi YH; Yao LP; Cui GB; Liang J; Shao QJ; Yan LF; Du P
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):172-80. PubMed ID: 24316043
[TBL] [Abstract][Full Text] [Related]
4. MTHFR A1298C polymorphism and ovarian cancer risk: a meta-analysis.
Shi XY; Shen Q
Genet Mol Res; 2015 Jul; 14(3):8211-8. PubMed ID: 26345746
[TBL] [Abstract][Full Text] [Related]
5. Methylenetetrahydrofolate reductase A1298C polymorphism and diabetes risk: evidence from a meta-analysis.
Yan Y; Liang H; Yang S; Wang J; Xie L; Qin X; Li S
Ren Fail; 2014 Aug; 36(7):1013-7. PubMed ID: 24828322
[TBL] [Abstract][Full Text] [Related]
6. Significant association between MTHFR C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Sun H; Han B; Zhai H; Cheng X; Ma K
Tumour Biol; 2014 Jan; 35(1):189-93. PubMed ID: 24132589
[TBL] [Abstract][Full Text] [Related]
7. The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer.
Lv L; Wang P; Sun B; Chen G
Tumour Biol; 2014 Jan; 35(1):227-37. PubMed ID: 23897558
[TBL] [Abstract][Full Text] [Related]
8. Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population.
Qi X; Sun X; Xu J; Wang Z; Zhang J; Peng Z
Tumour Biol; 2014 Mar; 35(3):1757-62. PubMed ID: 24385382
[TBL] [Abstract][Full Text] [Related]
9. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
Li JF; Zheng EQ; Xie M
Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
[TBL] [Abstract][Full Text] [Related]
10. Methylenetetrahydrofolate reductase A1298C genetic variant& risk of schizophrenia: A meta-analysis.
Rai V; Yadav U; Kumar P; Yadav SK; Gupta S
Indian J Med Res; 2017 Apr; 145(4):437-447. PubMed ID: 28862175
[TBL] [Abstract][Full Text] [Related]
11. Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects.
Zhang S; Jiang J; Tang W; Liu L
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010931
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of the association between MTHFR rs1801131 polymorphism and risk of liver cancer.
Liang TJ; Liu H; Zhao XQ; Tan YR; Jing K; Qin CY
Tumour Biol; 2014 Jan; 35(1):339-43. PubMed ID: 24014085
[TBL] [Abstract][Full Text] [Related]
13. Relationship between methylenetetrahydrofolate reductase (MTHFR) A1298C gene polymorphism and type 2 diabetic nephropathy risk: a meta-analysis.
Zhang J; Xiao Y; Zhang XW; Gao ZQ; Han JH
Ren Fail; 2014 Jul; 36(6):974-8. PubMed ID: 24678913
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of the relationship between MTHFR gene A1298C polymorphism and the risk of adult stroke.
Zhang MJ; Hu ZC; Yin YW; Li BH; Liu Y; Liao SQ; Gao CY; Li JC; Zhang LL
Cerebrovasc Dis; 2014; 38(6):425-32. PubMed ID: 25472665
[TBL] [Abstract][Full Text] [Related]
15. MTHFR C677T and A1298C polymorphisms and cervical carcinoma susceptibility: meta-analyses based on 4,421 individuals.
Zhuo WL; Zhang L; Ling JJ; Zhu Y; Chen ZT
Mol Biol Rep; 2012 Sep; 39(9):8723-32. PubMed ID: 22711309
[TBL] [Abstract][Full Text] [Related]
16. Association between MTHFR gene polymorphisms (C677T, A1298C) and genetic susceptibility to prostate cancer: a meta-analysis.
Chen PL; Li WT; Wang J; Jiang YD; Wu P; Chen T; Zheng SB
Genet Mol Res; 2015 Dec; 14(4):19191-202. PubMed ID: 26782572
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between methylenetetrahydrofolate reductase gene A1298C polymorphism and breast cancer susceptibility.
Qiu LX; Zhang J; Li WH; Zhang QL; Yu H; Wang BY; Wang LP; Wang JL; Wang HJ; Liu XJ; Luo ZG; Wu XH
Mol Biol Rep; 2011 Apr; 38(4):2295-9. PubMed ID: 21052845
[TBL] [Abstract][Full Text] [Related]
18. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population.
Mu LN; Cao W; Zhang ZF; Cai L; Jiang QW; You NC; Goldstein BY; Wei GR; Chen CW; Lu QY; Zhou XF; Ding BG; Chang J; Yu SZ
Cancer Causes Control; 2007 Aug; 18(6):665-75. PubMed ID: 17503006
[TBL] [Abstract][Full Text] [Related]
19. No association between MTHFR A1298C gene polymorphism and head and neck cancer risk: a meta-analysis based on 9,952 subjects.
Niu YM; Shen M; Li H; Ni XB; Zhou J; Zeng XT; Leng WD; Wu MY
Asian Pac J Cancer Prev; 2012; 13(8):3943-7. PubMed ID: 23098497
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of the effect of MTHFR polymorphisms on the risk of lung carcinoma.
Zhang Y; Chen GQ; Ji Y; Huang B; Shen WS; Deng LC; Xi L; Cao XM
Mol Biol Rep; 2012 May; 39(5):6203-11. PubMed ID: 22215214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
